KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Dec 2024 value amounting to $349.2 million.

  • Regeneron Pharmaceuticals' Prepaid Assets rose 44.56% to $595.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $595.6 million, marking a year-over-year increase of 44.56%. This contributed to the annual value of $349.2 million for FY2024, which is 9.67% down from last year.
  • According to the latest figures from FY2024, Regeneron Pharmaceuticals' Prepaid Assets is $349.2 million, which was down 9.67% from $386.6 million recorded in FY2023.
  • In the past 5 years, Regeneron Pharmaceuticals' Prepaid Assets ranged from a high of $411.2 million in FY2022 and a low of $160.8 million during FY2020.
  • Moreover, its 3-year median value for Prepaid Assets was $386.6 million (2023), whereas its average is $382.3 million.
  • Per our database at Business Quant, Regeneron Pharmaceuticals' Prepaid Assets slumped by 41.25% in 2020 and then skyrocketed by 106.72% in 2021.
  • Regeneron Pharmaceuticals' Prepaid Assets (Yearly) stood at $160.8 million in 2020, then surged by 106.72% to $332.4 million in 2021, then rose by 23.71% to $411.2 million in 2022, then fell by 5.98% to $386.6 million in 2023, then fell by 9.67% to $349.2 million in 2024.